AHA 2020 Archives - Medical Conferences

Home > Cardiology > AHA 2020

American Heart Association
3–17 November 2020

Featured articles

Letter from the Editor

Editor

Prof. Marc Bonaca, University of Colorado, USA

Conference

AHA 2020

24 February, 2021 07:59

AHA 2020 Highlights Podcast

Presented By

Dr Rachel Giles, Medicom

Conference

AHA 2020

18 November, 2020 12:39

Online First

COVID-19 and Influenza

Fewer CV complications than expected in AHA COVID-19 Registry

Presented By

Prof. James de Lemos, University of Texas Southwestern Medical Center, USA

Trial

AHA COVID-19 CVD Registry

Conference

AHA 2020

17 February, 2021 13:39

Worse COVID-19 outcomes in younger obese patients

Presented By

Dr Nicholas Hendren, University of Texas Southwestern, USA

Trial

AHA COVID-19 CVD Registry

Conference

AHA 2020

17 February, 2021 13:28

Effects of CVD in hospitalised COVID-19 patients

Presented By

Prof. Ann Marie Navar, University of Texas Southwestern, USA

Conference

AHA 2020

17 February, 2021 13:22

Meta-analyses: ACEI/ARB and COVID-19

Presented By

Dr Yujiro Yokoyama, St. Luke's University Hospital

Conference

AHA 2020

17 February, 2021 13:18

Unfavourable outcomes for COVID-19 patients with AF and atrial flutter

Presented By

Dr Zaniar Ghazizadeh, Brigham and Women’s Hospital, USA

Trial

Yale Cardiovascular COVID Registry

Conference

AHA 2020

17 February, 2021 12:08

High-dose influenza vaccine in patients with CVD

Presented By

Prof. Orly Vardeny, University of Minnesota Medical School, USA

Trial

Phase 4, INVESTED

Conference

AHA 2020

17 February, 2021 10:36

Atrial Fibrillation

Vitamin D or omega 3 fatty acids do not prevent AF

Presented By

Prof. Christine Albert, Cedars-Sinai Medical Center, USA

Trial

VITAL Rhythm

Conference

AHA 2020

17 February, 2021 14:19

Active screening for AF improves clinical outcomes

Presented By

Dr Steven Steinhubl, Scripps Research Translational Institute, USA

Trial

mSToPS

Conference

AHA 2020

17 February, 2021 14:16

AF screening in older adults at primary care visits

Presented By

Dr Steven Lubitz, Massachusetts General Hospital, USA

Trial

VITAL-AF

Conference

AHA 2020

17 February, 2021 14:06

CVD Risk Reduction

Clever trial design gets patients back on statins: the SAMSON trial

Presented By

Dr James Howard, Imperial College London, UK

Trial

SAMSON

Conference

AHA 2020

17 February, 2021 15:10

Polypill plus aspirin reduces cardiovascular events

Presented By

Prof. Salim Yusuf, Population Health Research Institute, Canada

Trial

TIPS-3

Conference

AHA 2020

17 February, 2021 14:58

Lowering LDL cholesterol in older patients is beneficial

Presented By

Dr Baris Gencer, Brigham and Women’s Hospital, USA

Conference

AHA 2020

17 February, 2021 14:54

No CV benefit from omega 3 in high-risk patients

Presented By

Prof. Michael Lincoff, Cleveland Clinic, USA

Trial

STRENGTH

Conference

AHA 2020

17 February, 2021 14:44

Safety and efficacy of inclisiran for hypercholesterolemia

Presented By

Prof. R. Scott Wright, Mayo Clinic, USA

Trial

Phase 3, ORION

Conference

AHA 2020

17 February, 2021 14:37

Remote risk management programme effective and efficient

Presented By

Prof. Benjamin Scirica, Brigham and Women’s Hospital, USA

Conference

AHA 2020

17 February, 2021 14:31

Healthy lifestyle lowers mortality irrespective of medication burden

Presented By

Dr Neil Kelly, Weill Cornell University, USA

Trial

REGARDS

Conference

AHA 2020

17 February, 2021 14:24

Heart Failure

Omecamtiv mecarbil improves outcomes in HFrEF-patients

Presented By

Prof. John Teerlink, University of California, San Francisco, USA

Trial

GALACTIC-HF

Conference

AHA 2020

18 February, 2021 10:25

IV iron reduces HF hospitalisation

Presented By

Prof. Piotr Ponikowski, Wroclaw Medical University, Poland

Trial

AFFIRM-AHF

Conference

AHA 2020

18 February, 2021 10:22

Dapagliflozin reduces renal risk independent of CV disease status

Presented By

Prof. John McMurray, University of Glasgow, Scotland

Trial

DAPA-CKD

Conference

AHA 2020

18 February, 2021 10:18

“Strongly consider an SGLT2-inhibitor in most T2DM patients”

Presented By

Prof. Deepak Bhatt, Brigham and Women’s Hospital, USA

Trial

Phase 3, SOLOIST-WHF; SCORED

Conference

AHA 2020

18 February, 2021 10:14

Additional HFrEF education and patient-engagement tools

Presented By

Prof. Larry Allen, University of Colorado School of Medicine, USA

Trial

EPIC-HF

Conference

AHA 2020

18 February, 2021 10:09

Acute Coronary Syndrome

No benefit from omega-3 fatty acids after recent MI

Presented By

Dr Are Kalstad, Oslo University Hospital, Norway

Trial

OMEMI

Conference

AHA 2020

18 February, 2021 10:34

PIONEER III trial: Drug-eluting stents comparable

Presented By

Prof. Alexandra Lansky, Yale School of Medicine, USA

Trial

PIONEER III

Conference

AHA 2020

18 February, 2021 10:30

Coronary and Valve Disease

Extra imaging reveals cause of MINOCA in women

Presented By

Prof. Harmony Reynolds, New York University Grossman School of Medicine, USA

Trial

HARP-MINOCA

Conference

AHA 2020

18 February, 2021 10:50

Ticagrelor not superior to clopidogrel after elective PCI

Presented By

Prof. Johanne Silvain, Sorbonne University, France

Trial

Phase 3, ALPHEUS

Conference

AHA 2020

18 February, 2021 10:43

Stroke

Ticagrelor/aspirin reduces stroke risk in patients with ipsilateral cervicocranial plaque

Presented By

Prof. Pierre Amarenco, Paris University, France

Trial

THALES

Conference

AHA 2020

18 February, 2021 11:01

AF monitoring following cardiovascular surgery

Presented By

Prof. Subodh Verma, University of Toronto, Canada)

Trial

SEARCH-AF

Conference

AHA 2020

18 February, 2021 10:54

Miscellaneous

PAD: Rivaroxaban reduces VTE risk after revascularisation

Presented By

Dr Connie Hess; Prof. Judith Hsia

Trial

VOYAGER PAD

Conference

AHA 2020

18 February, 2021 11:45

Sotatercept: potential new treatment option for PAH

Presented By

Prof. Vallerie McLaughlin, University of Michigan, USA

Trial

Phase 2, PULSAR

Conference

AHA 2020

18 February, 2021 11:37

Finerenone lowers CV events in diabetic CKD patients

Presented By

Prof. Gerasimos Filippatos, National and Kapodistrian University of Athens, Greece

Trial

Phase 3, FIDELIO-DKD

Conference

AHA 2020

18 February, 2021 11:33

Mavacamten effective in obstructive hypertrophic cardiomyopathy

Presented By

Dr Sheila Hegde, Brigham and Women’s Hospital, USA

Trial

Phase 3, EXPLORER-HCM

Conference

AHA 2020

18 February, 2021 11:28

Children exposed to tobacco smoke have worse heart function as adults

Presented By

Dr Chigozie Ezegbe, University of Tasmania, Australia

Conference

AHA 2020

18 February, 2021 11:25

Transgender people have unaddressed heart disease risks

Presented By

Dr Kara Denby, Cleveland Clinic, USA

Conference

AHA 2020

18 February, 2021 11:23

Rilonacept reduces risk of pericarditis recurrence

Presented By

Dr Alan Klein, Cleveland Clinic, USA

Trial

Phase 3, RHAPSODY

Conference

AHA 2020

18 February, 2021 11:18

Intensive blood pressure lowering benefits older adults

Presented By

Prof. William Cushman, University of Tennessee Health Science, USA

Trial

SPRINT

Conference

AHA 2020

18 February, 2021 11:13

Dobutamine versus milrinone in cardiogenic shock

Trial

Capital Do-Re-Mi

Conference

AHA 2020

18 February, 2021 11:10

Longer chest compression pause worsens outcomes after paediatric IHCA

Presented By

Dr Kasper Glerup Lauridsen, Aarhus University, Denmark

Conference

AHA 2020

18 February, 2021 11:06

Featured articles

CONTENTS

Online First

COVID-19 and Influenza

Atrial Fibrillation

CVD Risk Reduction

Heart Failure

Acute Coronary Syndrome

Coronary and Valve Disease

Stroke

Miscellaneous